Potent and stable attenuation of live-HIV-1 by gain of a proteolysis-resistant inhibitor of NF-kappaB (IkappaB-alphaS32/36A) and the implications for vaccine development (Q40949172)

From Wikidata
Jump to navigation Jump to search
scientific article published on June 1999
edit
Language Label Description Also known as
English
Potent and stable attenuation of live-HIV-1 by gain of a proteolysis-resistant inhibitor of NF-kappaB (IkappaB-alphaS32/36A) and the implications for vaccine development
scientific article published on June 1999

    Statements

    Potent and stable attenuation of live-HIV-1 by gain of a proteolysis-resistant inhibitor of NF-kappaB (IkappaB-alphaS32/36A) and the implications for vaccine development (English)
    I Quinto
    M Mallardo
    F Baldassarre
    G Scala
    G Englund
    K T Jeang
    1 June 1999
    17567-17572

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit